Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 516,273 | 635,280 | 1,347,186 | 1,291,366 | 1,385,861 |
| Receivables | 394,890 | 112,849 | 82,375 | 111,645 | 194,533 |
| Inventories | 23,488 | 34,185 | 36,683 | 82,432 | 256,301 |
| TOTAL | $1,127,554 | $971,028 | $1,703,391 | $1,759,965 | $2,136,002 |
| Non-Current Assets | |||||
| PPE Net | 299,955 | 307,414 | 294,247 | 255,532 | 254,526 |
| Intangibles | 128,366 | 129,827 | 126,331 | 125,991 | 127,500 |
| Other Non-Current Assets | 129,173 | 134,430 | 134,710 | 125,949 | 104,965 |
| TOTAL | $557,494 | $571,671 | $555,288 | $507,472 | $486,991 |
| Total Assets | $1,685,048 | $1,542,699 | $2,258,679 | $2,267,437 | $2,622,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 87,246 | 124,801 | 216,517 | 144,997 | 386,488 |
| Accrued Expenses | 458,397 | 518,706 | 591,158 | 551,069 | 585,646 |
| Other current liabilities | 749,186 | 858,382 | 930,055 | 160,499 | 34,158 |
| TOTAL | $1,596,255 | $1,918,858 | $2,459,944 | $1,667,961 | $2,156,239 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 300,473 | 415,764 | 370,137 | 404,776 | 701,518 |
| Other Non-Current Liabilities | 205,631 | 214,368 | 222,161 | 98,569 | 69,075 |
| TOTAL | $843,312 | $519,423 | $432,813 | $1,165,461 | $883,704 |
| Total Liabilities | $2,439,567 | $2,438,281 | $2,892,757 | $2,833,422 | $3,039,943 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,404 | 86,305 | 86,173 | 78,504 | 78,215 |
| Common Shares | 952 | 871 | 868 | 792 | 788 |
| Retained earnings | -4,511,786 | -4,569,794 | -4,275,889 | -4,093,640 | -3,925,027 |
| Other shareholders' equity | -8,601 | -3,392 | -6,036 | -23,734 | -11,325 |
| TOTAL | $-754,519 | $-895,582 | $-634,078 | $-565,985 | $-416,950 |
| Total Liabilities And Equity | $1,685,048 | $1,542,699 | $2,258,679 | $2,267,437 | $2,622,993 |